Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

721 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sebaceous immunobiology - skin homeostasis, pathophysiology, coordination of innate immunity and inflammatory response and disease associations.
Zouboulis CC, Coenye T, He L, Kabashima K, Kobayashi T, Niemann C, Nomura T, Oláh A, Picardo M, Quist SR, Sasano H, Schneider MR, Törőcsik D, Wong SY. Zouboulis CC, et al. Front Immunol. 2022 Nov 10;13:1029818. doi: 10.3389/fimmu.2022.1029818. eCollection 2022. Front Immunol. 2022. PMID: 36439142 Free PMC article. Review.
Which Health-Related Quality of Life Items Most Affect Acne Patients?
Chernyshov PV, Sampogna F, Zouboulis CC, Boffa MJ, Marron SE, Manolache L, Pustišek N, Bettoli V, Koumaki D, Chubar O, Pochynok TV, Mintoff D, Bonitsis NG, Spillekom-van Koulil S, Driessen RJB, Chernyshov AV, Bewley AP, Evers AWM, Chernyshov IP, Tomas-Aragones L. Chernyshov PV, et al. Among authors: zouboulis cc. Dermatology. 2023;239(2):267-272. doi: 10.1159/000526602. Epub 2022 Dec 7. Dermatology. 2023. PMID: 36476839
Acne lesions cycle.
Zouboulis CC, Kollias N. Zouboulis CC, et al. J Eur Acad Dermatol Venereol. 2024 May 2. doi: 10.1111/jdv.20061. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38695690 No abstract available.
TRPV3 promotes sebocyte inflammation via transcriptional modulating TLR2 in acne.
Wei Z, Gao M, Liu Y, Zeng R, Liu J, Sun S, Li S, Hu L, Xiang R, Mo R, Song Z, Chen Z, Bao D, Hua D, Zouboulis CC, Feng Y, Li J, Yang Y. Wei Z, et al. Among authors: zouboulis cc. Biochim Biophys Acta Mol Basis Dis. 2024 Apr 20;1870(5):167195. doi: 10.1016/j.bbadis.2024.167195. Online ahead of print. Biochim Biophys Acta Mol Basis Dis. 2024. PMID: 38648901
Discrepancies in hidradenitis suppurativa lesion characterization by providers and patients.
Greenlund L, Herzog C, Wendland Z, Rypka K, Frew JW, Kirby JS, Alavi A, Khalid B, Lowes MA, Garg A, Marzano AV, Zouboulis CC, Tzellos T, Jaleel T, Goldfarb N. Greenlund L, et al. Among authors: zouboulis cc. J Eur Acad Dermatol Venereol. 2024 Apr 10. doi: 10.1111/jdv.19999. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38595320
Proof-of-concept study exploring the effect of spesolimab in patients with moderate-to-severe hidradenitis suppurativa: A randomized, double-blind, placebo-controlled clinical trial.
Alavi A, Prens E, Kimball AB, Frew JW, Krueger JG, Mukhopadhyay S, Gao H, Ranganathan U, Ivanoff NB, Hernandez Daly AC, Zouboulis CC. Alavi A, et al. Among authors: zouboulis cc. Br J Dermatol. 2024 Apr 5:ljae144. doi: 10.1093/bjd/ljae144. Online ahead of print. Br J Dermatol. 2024. PMID: 38576350
Primary Cutaneous Melanoma-Management in 2024.
Dixon AJ, Sladden M, Zouboulis CC, Popescu CM, Nirenberg A, Steinman HK, Longo C, Dixon ZL, Thomas JM. Dixon AJ, et al. Among authors: zouboulis cc. J Clin Med. 2024 Mar 11;13(6):1607. doi: 10.3390/jcm13061607. J Clin Med. 2024. PMID: 38541831 Free PMC article.
Secukinumab in patients with moderate to severe hidradenitis suppurativa based on prior biologic exposure: An efficacy and safety analysis from the SUNSHINE and SUNRISE phase III trials.
Zouboulis CC, Passeron T, Pariser D, Wozniak MB, Li X, Uhlmann L, Lobach I, Martinez AL, Ravichandran S, Alarcon I, Offidani A, Alam MS, Mendes-Bastos P. Zouboulis CC, et al. Br J Dermatol. 2024 Mar 12:ljae098. doi: 10.1093/bjd/ljae098. Online ahead of print. Br J Dermatol. 2024. PMID: 38470171
721 results